recall
saveMckesson Medical-Surgical Inc. Corporate Office recall (Cls II)
community read0 votes
EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02. — Reason: CGMP Deviations; potential temperature excursions due to transit delays — Status: Ongoing
view source ↗Data sources
last refreshed 21m ago
Found something off?
same company · ±60 days · 6
- recallMckesson Medical-Surgical Inc. Corporate Office recall (Cls II)Jul 30, 2025
- approvalapremilast: OTEZLA (APREMILAST) — FDA approvalJul 23, 2025
- approvalENBREL (ETANERCEPT) — FDA approvalJun 18, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalSep 17, 2025
- approvaleculizumab biosimilar: BKEMV (ECULIZUMAB-AEEB) — FDA approvalSep 17, 2025
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalSep 25, 2025
🐶 often sniffed alongside
top 8- tagApproval84 co-mentions · 42 sources
- drugOTEZLA28 co-mentions · 14 sources
- drugAMJEVITA26 co-mentions · 13 sources
- drugapremilast14 co-mentions · 14 sources
- drugBKEMV14 co-mentions · 7 sources
- drugapremilast ER14 co-mentions · 14 sources
- tagSmall Molecule14 co-mentions · 14 sources
- drugHUMIRA13 co-mentions · 13 sources
comments(0)
5-min edit window · permanent after that